Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Lonza Expands Florida Solid-Dose Facility

July 10, 2019

The expansion of Lonza’s Tampa site includes development and manufacturing capabilities for oral solid-dose drugs.

Amicus Partners with Catalent on Lysosomal Disease Gene Therapy Programs

July 03, 2019

Metabolic-disease biotech Amicus Therapeutics announced a manufacturing agreement with Catalent’s Paragon Gene Therapy unit for gene therapy manufacturing.

Gene Therapies Propel Outsourcing Investment

July 02, 2019

The increasing growth in the cell- and gene-therapy markets is inspiring CDMOs to expand their services in this emerging biologic drug arena.

Catalent Biologics Acquires Vaccine Manufacturing Facilities

July 01, 2019

Novavax will sell two Maryland-based vaccine development and manufacturing facilities for Catalent’s expanding gene therapy footprint.

Applying Operational Excellence to Improve Injectable Pharmaceuticals Production

June 24, 2019

Using Lean, Six Sigma, and other Op Ex practices is helping one contract development and manufacturing organization (CDMO) increase efficiency and optimization.

Catalent to Purchase BMS Manufacturing Site in Anagni, Italy

June 19, 2019

Catalent will manufacture products for Bristol-Myers Squibb while adding sterile biologics fill/finish and oral solids manufacturing and packaging capacity.

LSNE Expands to Europe with Acquisition of Facility in Spain

June 19, 2019

Lyophilization Services of New England acquired a sterile injectables manufacturing facility in León, Spain.

Concept Life Sciences Opens New API Facility in UK

June 19, 2019

New CDMO facility supports early-stage API manufacturing and scale up.

Lonza Expands HPAPI Capacity

June 17, 2019

Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.

FUJIFILM Invests in New Continuous Processing Facility

June 07, 2019

The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.